Stoke Therapeutics (STOK) Tax Rate (2025)

Stoke Therapeutics' (STOK) quarterly Tax Rate came in at 3.23% in Q3 2025, up 188.09% quarter-over-quarter from 1.12% in Q1 2025.

Stoke Therapeutics (STOK) Tax Rate (2025) Analysis & Trends

Stoke Therapeutics' Tax Rate history runs 1 years deep, the most recent figure standing at 3.23% for Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-0.34
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	5.61
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	12.29
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	17.68
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	12.51
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-13.70
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Stoke Therapeutics	1.86 Bn	1.51 Bn	-	-

Download Data